These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19015643)

  • 1. A possible suppressive role of galectin-3 in upregulated osteoclastogenesis accompanying adjuvant-induced arthritis in rats.
    Li YJ; Kukita A; Teramachi J; Nagata K; Wu Z; Akamine A; Kukita T
    Lab Invest; 2009 Jan; 89(1):26-37. PubMed ID: 19015643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nordihydroguaiaretic acid inhibition of NFATc1 suppresses osteoclastogenesis and arthritis bone destruction in rats.
    Li YJ; Kukita A; Watanabe T; Takano T; Qu P; Sanematsu K; Ninomiya Y; Kukita T
    Lab Invest; 2012 Dec; 92(12):1777-87. PubMed ID: 23044922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Water-soluble fullerene (C60) inhibits the osteoclast differentiation and bone destruction in arthritis.
    Yudoh K; Karasawa R; Masuko K; Kato T
    Int J Nanomedicine; 2009; 4():233-9. PubMed ID: 19918370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of MIP-1alpha in the recruitment of osteoclast progenitors to the distal tibia in rats with adjuvant-induced arthritis.
    Toh K; Kukita T; Wu Z; Kukita A; Sandra F; Tang QY; Nomiyama H; Iijima T
    Lab Invest; 2004 Sep; 84(9):1092-102. PubMed ID: 15195117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis.
    Teramachi J; Kukita A; Li YJ; Ushijima Y; Ohkuma H; Wada N; Watanabe T; Nakamura S; Kukita T
    Lab Invest; 2011 May; 91(5):719-31. PubMed ID: 21339747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.
    Huh JE; Jung IT; Choi J; Baek YH; Lee JD; Park DS; Choi DY
    Eur J Pharmacol; 2013 Jan; 698(1-3):57-66. PubMed ID: 22985747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of ribbon-type NF-kappaB decoy oligodeoxynucleotides on osteoclast induction and activity in vitro and in vivo.
    Kunugiza Y; Tomita T; Tomita N; Morishita R; Yoshikawa H
    Arthritis Res Ther; 2006; 8(4):R103. PubMed ID: 16813665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of ZSTK474, a novel phosphoinositide 3-kinase inhibitor, on osteoclasts and collagen-induced arthritis in mice.
    Toyama S; Tamura N; Haruta K; Karakida T; Mori S; Watanabe T; Yamori T; Takasaki Y
    Arthritis Res Ther; 2010; 12(3):R92. PubMed ID: 20482767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of osteoclastogenesis by Simon extracts composed of caffeic acid and related compounds: successful suppression of bone destruction accompanied with adjuvant-induced arthritis in rats.
    Tang QY; Kukita T; Ushijima Y; Kukita A; Nagata K; Sandra F; Watanabe T; Toh K; Okuma Y; Kawasaki S; Rasubala L; Teramachi J; Miyamoto I; Wu Z; Iijima T
    Histochem Cell Biol; 2006 Mar; 125(3):215-25. PubMed ID: 16205940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylserine-containing liposomes inhibit the differentiation of osteoclasts and trabecular bone loss.
    Wu Z; Ma HM; Kukita T; Nakanishi Y; Nakanishi H
    J Immunol; 2010 Mar; 184(6):3191-201. PubMed ID: 20176740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
    Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T
    Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of histone deacetylase suppresses osteoclastogenesis and bone destruction by inducing IFN-beta production.
    Nakamura T; Kukita T; Shobuike T; Nagata K; Wu Z; Ogawa K; Hotokebuchi T; Kohashi O; Kukita A
    J Immunol; 2005 Nov; 175(9):5809-16. PubMed ID: 16237073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation.
    Hirayama T; Dai S; Abbas S; Yamanaka Y; Abu-Amer Y
    Arthritis Rheum; 2005 Sep; 52(9):2719-29. PubMed ID: 16142755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS production.
    Lee SY; Lee KS; Yi SH; Kook SH; Lee JC
    PLoS One; 2013; 8(12):e80873. PubMed ID: 24324641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
    Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
    Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of osteoclastogenesis through Tim-3: possible involvement of the Tim-3/galectin-9 system in the modulation of inflammatory bone destruction.
    Moriyama K; Kukita A; Li YJ; Uehara N; Zhang JQ; Takahashi I; Kukita T
    Lab Invest; 2014 Nov; 94(11):1200-11. PubMed ID: 25264706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model.
    Mukai T; Gallant R; Ishida S; Yoshitaka T; Kittaka M; Nishida K; Fox DA; Morita Y; Ueki Y
    PLoS One; 2014; 9(8):e105518. PubMed ID: 25144740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.